Investec Bank Plc has filed a Form 8.5 regulatory dealing disclosure relating to Advanced Medical Solutions Group Plc (AMS.L) under Rule 8.5 of the Takeover Code.
The disclosure was made in Investec’s capacity as an exempt principal trader with recognised intermediary status, dealing in a client-serving capacity.
Investec serves as Advisor and Joint Broker to Advanced Medical Solutions Group Plc, establishing its connected status in relation to the offer.
The dealings were undertaken on 15th September 2026, with the disclosure formally filed on 16th September 2026.
On the purchase side, Investec acquired a total of 1,044,392 ordinary shares, with the highest price paid per unit standing at 281p and the lowest at 280.75p.
On the sales side, the firm sold 912,238 ordinary shares, with prices ranging from a high of 281.25p to a low of 280.75p per unit.
No cash-settled derivative transactions were reported as part of this disclosure, with all relevant fields returned as not applicable.
Similarly, no stock-settled derivative transactions, including options, were recorded in either the writing, selling, purchasing, or exercise categories.
Investec confirmed there are no indemnity arrangements, options, or formal or informal agreements that could serve as an inducement to deal or refrain from dealing in relevant securities.
The bank also confirmed no agreements or understandings exist relating to voting rights or the future acquisition or disposal of relevant securities linked to any derivative.
The contact named in the disclosure is Priyali Bhattacharjee, reachable by telephone for any enquiries related to the filing.
Public disclosures under Rule 8 of the Takeover Code are required to be made to a Regulatory Information Service, as mandated by the Panel on Takeovers and Mergers.
